| Q43653145 | A series of enediynes as novel inhibitors of topoisomerase I. |
| Q33779886 | Calicheamicin-DNA complexes: warhead alignment and saccharide recognition of the minor groove |
| Q24562475 | Chemistry and biology of natural and designed enediynes |
| Q24561724 | Cleavage behavior of calicheamicin gamma 1 and calicheamicin T |
| Q35690179 | Crystal structure of O-methyltransferase CalO6 from the calicheamicin biosynthetic pathway: a case of challenging structure determination at low resolution |
| Q41623727 | Designed enediynes: a new class of DNA-cleaving molecules with potent and selective anticancer activity |
| Q67470988 | Engineering Antibodies for Therapy |
| Q90438199 | Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia |
| Q39218600 | Heteroatom-Heteroatom Bond Formation in Natural Product Biosynthesis |
| Q52184933 | Humanized antibodies as potential therapeutic drugs. |
| Q35909309 | Immunotoxins and toxin constructs in the treatment of leukemia and lymphoma |
| Q60915299 | Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia |
| Q35627787 | Interaction of calicheamicin gamma1(I) and its related carbohydrates with DNA-protein complexes |
| Q37224944 | Intervention of carbohydrate recognition by proteins and nucleic acids |
| Q36202066 | Kedarcidin chromophore: an enediyne that cleaves DNA in a sequence-specific manner |
| Q41188568 | Mechanisms of target selection by DNA-damaging chemicals: studies with enediyne anticancer drugs |
| Q37814157 | Natural glycoconjugates with antitumor activity |
| Q56979491 | Novel insights on the DNA interaction of calicheamicin γ1I |
| Q35771242 | Organic synthesis and cell biology: partners in controlling gene expression |
| Q37809500 | Probing the Biology of Natural Products: Molecular Editing by Diverted Total Synthesis |
| Q72707290 | Regulation of apoptosis in leukemic cells by analogs of dynemicin A |
| Q36471589 | Simultaneous determination of helical unwinding angles and intrinsic association constants in ligand-DNA complexes: the interaction between DNA and calichearubicin B. |
| Q35771896 | Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: a paradigm for the development of transcriptional antagonists |
| Q37907992 | Structural and conformational features relevant to the anti-tumor activity of calicheamicin γ 1I. |
| Q33266307 | The DNA-damage signature in Saccharomyces cerevisiae is associated with single-strand breaks in DNA. |
| Q33877323 | The cytotoxicity of (-)-lomaiviticin A arises from induction of double-strand breaks in DNA. |
| Q77732327 | Transcriptional effects of the potent enediyne anti-cancer agent Calicheamicin gamma(I)(1) |
| Q38303120 | Use of triethylene glycol to mimic oligosaccharides: design and synthesis of a ligand based on chromomycin A3. |